Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.5.0.2
Accrued Expenses
6 Months Ended
Jun. 30, 2016
Payables and Accruals [Abstract]  
Accrued Expenses

7. ACCRUED EXPENSES

 

Accrued expenses consisted of the following:

 

    June 30, 2016     December 31, 2015  
             
Accrued clinical operations and trials costs   $ 1,302,309     $ 365,188  
Accrued product development costs     405,578       152,018  
Accrued audit fees     1,500       16,500  
Accrued payroll and related     109,442       -  
Accrued other     96,222       28,573  
Total   $ 1,915,051     $ 562,279